1. What You’ll Learn: The five core elements of a business case: • Scenario Analysis • Cause/Effect Analysis • Key performance indicators • Risk of the status quo…

1. 20/03/2014 1 NOUVELLES EXIGENCES EN PHARMACOVIGILANCE EN E.C. 4èmes RENCONTRE DE LA RECHERCHE CLINIQUE , DES ARCs & DES TECs, CNIT PARIS LA DÉFENSE 20 MARS 2014…

1. Natalizumab Safety Update & PML Risk Stratification Professor Gavin GiovannoniBarts and The LondonTY-PAN-0587(2) Date of preparation: March 2013 2. Benefit / Risk…

1. Natalizumab Safety Update & PMLRisk StratificationBarts Health September 2012 Gavin GiovannoniProfessor of NeurologyTY-PAN-0463r Date of preparation: September…

1. TYSABRI Safety Update & PML Risk Stratification Barts and The London October 2012Professor Gavin Giovannoni TY-PAN-0463s Date of preparation: October 2012 2. Benefit…

1. TYSABRI Safety Update & PML Risk Stratification Barts HealthJanuary 2013 Gavin Giovannoni TY-PAN-0587 Date of preparation: January 2013 2. Benefit / Risk 81% reduction…

1. TYSABRI Safety Update & PML Risk StratificationBarts Health NHS Trust25th AugustProfessor Gavin GiovannoniTY-PAN-0463q Date of preparation: July 2012 2. Benefit…

1. Natalizumab Safety Update & PMLRisk Stratification Barts Health 25th December 2012 Gavin GiovannoniProfessor of Neurology TY-PAN-0463u Date of preparation: December…

1. General principles of Periodic Safety Update Reports (PSUR) 2014-09-26 Dr. Julia Appelskog EU QPPV Head of Pharmacovigilance Bluefish Pharmaceuticals 2014-09-26 2. 2 PUBLIC…

1. 0 The Patient Perspective In Drug Development Pauline McNulty April 13th, 2015 2. 1 The Healthcare World is Changing 3. 2 Transformation of Patient Involvement in Healthcare:…